Benmoxin

Benmoxin

Clinical data
Routes of administration	Oral
ATC code	None
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name N'-(1-phenylethyl)benzohydrazide
CAS Number	7654-03-7 N
PubChem CID	71671
ChemSpider	64728 Y
UNII	XC9FY2SGBG
ChEMBL	ChEMBL1877495 N
CompTox Dashboard (EPA)	DTXSID0046220
ECHA InfoCard	100.028.745
Chemical and physical data
Formula	C15H16N2O
Molar mass	240.306 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(NNC(c1ccccc1)C)c2ccccc2
InChI InChI=1S/C15H16N2O/c1-12(13-8-4-2-5-9-13)16-17-15(18)14-10-6-3-7-11-14/h2-12,16H,1H3,(H,17,18) Y Key:BEWNZPMDJIGBED-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class. It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.

See also

• Hydrazine (antidepressant)